DEUTSCHE BANK AG\ - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$398,000
-56.5%
42,476
+14.0%
0.00%
Q2 2023$913,914
-65.6%
37,257
-67.4%
0.00%
-100.0%
Q1 2023$2,657,597
-26.6%
114,207
-20.2%
0.00%
-50.0%
Q4 2022$3,621,532
+377.1%
143,087
+263.2%
0.00%
Q3 2022$759,000
-31.1%
39,395
-8.9%
0.00%
-100.0%
Q2 2022$1,101,000
-3.8%
43,240
-2.8%
0.00%0.0%
Q1 2022$1,144,000
-43.3%
44,478
-7.8%
0.00%0.0%
Q4 2021$2,019,000
-7.0%
48,226
-3.4%
0.00%0.0%
Q3 2021$2,171,000
-2.6%
49,902
+5.9%
0.00%0.0%
Q2 2021$2,228,000
+3.9%
47,140
+12.7%
0.00%0.0%
Q1 2021$2,145,000
+75.1%
41,830
-8.5%
0.00%0.0%
Q4 2020$1,225,000
+15.9%
45,728
+48.5%
0.00%0.0%
Q3 2020$1,057,000
+10.3%
30,803
+31.7%
0.00%0.0%
Q2 2020$958,000
+1014.0%
23,393
+839.1%
0.00%
Q1 2020$86,000
+152.9%
2,491
-11.4%
0.00%
Q4 2019$34,0002,8110.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders